Puretech founded entity sonde health and massachusetts general hospital selected for national institute on aging study to examine use of voice in remote detection and monitoring of mild cognitive impairment including frontotemporal disorders (ftd)

Boston--(business wire)--puretech health plc (nasdaq: prtc, lse: prtc) (“puretech” or the “company”), a clinical-stage biotherapeutics company, noted today that its founded entity, sonde health, a health technology company committed to bringing accessible health monitoring to everyone, in conjunction with the massachusetts general hospital (mgh) frontotemporal disorders (ftd) unit, has been selected by the massachusetts artificial intelligence and technology center for connected care in aging &
PRTC Ratings Summary
PRTC Quant Ranking